These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1928022)

  • 1. Predictors of opiate drug abuse during a 90-day methadone detoxification.
    Iguchi MY; Stitzer ML
    Am J Drug Alcohol Abuse; 1991 Sep; 17(3):279-94. PubMed ID: 1928022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug abuse treatment as HIV prevention: changes in social drug use patterns might also reduce risk.
    Iguchi MY
    J Addict Dis; 1998; 17(4):9-18. PubMed ID: 9848028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with relapse among opiate addicts in an out-patient detoxification programme.
    Unnithan S; Gossop M; Strang J
    Br J Psychiatry; 1992 Nov; 161():654-7. PubMed ID: 1422615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients.
    Backmund M; Meyer K; Eichenlaub D; Schütz CG
    Drug Alcohol Depend; 2001 Oct; 64(2):173-80. PubMed ID: 11543987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic opiate use during methadone detoxification: effects of a dose increase treatment.
    Stitzer ML; McCaul ME; Bigelow GE; Liebson IA
    Drug Alcohol Depend; 1984 Sep; 14(1):37-44. PubMed ID: 6489151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circumstances surrounding the initial lapse to opiate use following detoxification.
    Bradley BP; Phillips G; Green L; Gossop M
    Br J Psychiatry; 1989 Mar; 154():354-9. PubMed ID: 2597837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differences in depression severity and frequency of relapses in opiate addicts treated with methadone or opiate blocker after detoxification].
    Jovanović T; Lazarević D; Nikolić G
    Vojnosanit Pregl; 2012 Apr; 69(4):326-32. PubMed ID: 22624424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voucher-based reinforcement of opiate abstinence during methadone detoxification.
    Robles E; Stitzer ML; Strain EC; Bigelow GE; Silverman K
    Drug Alcohol Depend; 2002 Jan; 65(2):179-89. PubMed ID: 11772479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance with tuberculosis treatment in methadone-maintained patients: behavioral interventions.
    Elk R; Grabowski J; Rhoades H; Spiga R; Schmitz J; Jennings W
    J Subst Abuse Treat; 1993; 10(4):371-82. PubMed ID: 8411296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcome in methadone detoxification: relationship to initial levels of illicit opiate use.
    Stitzer ML; McCaul ME; Bigelow GE; Liebson I
    Drug Alcohol Depend; 1983 Nov; 12(3):259-67. PubMed ID: 6653395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
    Kamal F; Flavin S; Campbell F; Behan C; Fagan J; Smyth R
    Ir Med J; 2007 Mar; 100(3):393-7. PubMed ID: 17491538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors associated with noncompliance with methadone substitution therapy (MST) and relapse among chronic opiate users in an Outer London community.
    Mutasa HC
    J Adv Nurs; 2001 Jul; 35(1):97-107. PubMed ID: 11442687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inpatient opiate detoxification in Geneva: follow-up at 1 and 6 months.
    Broers B; Giner F; Dumont P; Mino A
    Drug Alcohol Depend; 2000 Feb; 58(1-2):85-92. PubMed ID: 10669058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial.
    Robertson JR; Raab GM; Bruce M; McKenzie JS; Storkey HR; Salter A
    Addiction; 2006 Dec; 101(12):1752-9. PubMed ID: 17156174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contingency management interventions: effects on treatment outcome during methadone detoxification.
    McCaul ME; Stitzer ML; Bigelow GE; Liebson IA
    J Appl Behav Anal; 1984; 17(1):35-43. PubMed ID: 6725168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can opiate addicts tell us about their relapse risk? Subjective predictors of clinical prognosis.
    Powell J; Dawe S; Richards D; Gossop M; Marks I; Strang J; Gray J
    Addict Behav; 1993; 18(4):473-90. PubMed ID: 8213302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users.
    Schütz CG; Rapiti E; Vlahov D; Anthony JC
    Drug Alcohol Depend; 1994 Oct; 36(2):129-38. PubMed ID: 7851280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opiate treatments.
    Johns A
    Addiction; 1994 Nov; 89(11):1551-8. PubMed ID: 7841870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome.
    Saxon AJ; Wells EA; Fleming C; Jackson TR; Calsyn DA
    Addiction; 1996 Aug; 91(8):1197-209. PubMed ID: 8828247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcome predictors in flexible dose-duration methadone detoxification program.
    Ekhtiari H; Dezfouli A; Zamanian B; Ghodousi A; Mokri A
    Arch Iran Med; 2013 Oct; 16(10):599-601. PubMed ID: 24093142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.